These findings are in line with previous evidence showing that the inhibition of SPT in AML with compound-2 exerts anti-leukemic effects [181] and support a pro-survival activity by SPT in AML and in response to resveratrol. The gene discussed is AGXT; the disease is acute myeloid leukemia.